Research Analysts Offer Predictions for Tabula Rasa HealthCare Inc’s Q4 2018 Earnings (TRHC)

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) – Equities researchers at William Blair cut their Q4 2018 earnings per share (EPS) estimates for shares of Tabula Rasa HealthCare in a research note issued to investors on Tuesday, November 6th. William Blair analyst R. Daniels now forecasts that the company will post earnings of $0.09 per share for the quarter, down from their previous forecast of $0.13.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.53%. The business had revenue of $54.42 million for the quarter, compared to analysts’ expectations of $52.87 million. During the same period in the prior year, the company posted $0.08 EPS. The business’s revenue for the quarter was up 66.3% compared to the same quarter last year.

A number of other brokerages have also commented on TRHC. Robert W. Baird reissued a “buy” rating and issued a $70.00 price target on shares of Tabula Rasa HealthCare in a report on Wednesday, August 8th. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 14th. Stifel Nicolaus started coverage on shares of Tabula Rasa HealthCare in a research report on Tuesday, September 11th. They set a “hold” rating and a $95.00 price target for the company. Oppenheimer lifted their price target on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, August 23rd. Finally, Piper Jaffray Companies lifted their price target on shares of Tabula Rasa HealthCare to $71.00 and gave the company an “overweight” rating in a research report on Wednesday, August 8th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Tabula Rasa HealthCare presently has an average rating of “Buy” and an average target price of $81.60.

Shares of NASDAQ:TRHC opened at $73.81 on Friday. The firm has a market capitalization of $1.36 billion, a PE ratio of -1,845.25, a P/E/G ratio of 5.08 and a beta of 2.58. Tabula Rasa HealthCare has a one year low of $27.10 and a one year high of $91.16. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.33 and a current ratio of 0.36.

In related news, President Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, August 17th. The shares were sold at an average price of $72.23, for a total transaction of $577,840.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 48,000 shares of company stock valued at $3,722,960 over the last 90 days. 14.00% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Mount Yale Investment Advisors LLC bought a new stake in Tabula Rasa HealthCare during the second quarter valued at approximately $111,000. Meadow Creek Investment Management LLC bought a new stake in Tabula Rasa HealthCare during the second quarter valued at approximately $115,000. Envestnet Asset Management Inc. bought a new stake in Tabula Rasa HealthCare during the second quarter valued at approximately $130,000. Mckinley Capital Management LLC Delaware grew its position in Tabula Rasa HealthCare by 60.5% during the second quarter. Mckinley Capital Management LLC Delaware now owns 2,431 shares of the company’s stock valued at $155,000 after buying an additional 916 shares during the period. Finally, Pinebridge Investments L.P. bought a new stake in Tabula Rasa HealthCare during the second quarter valued at approximately $181,000. Institutional investors own 75.88% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: What is the Ex-Dividend Date in Investing?

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply